Cargando…

Community screening and treatment of asymptomatic carriers of Plasmodium falciparum with artemether-lumefantrine to reduce malaria disease burden: a modelling and simulation analysis

BACKGROUND: Asymptomatic carriers of Plasmodium falciparum serve as a reservoir of parasites for malaria transmission. Identification and treatment of asymptomatic carriers within a region may reduce the parasite reservoir and influence malaria transmission in that area. METHODS: Using computer simu...

Descripción completa

Detalles Bibliográficos
Autores principales: Kern, Steven E, Tiono, Alfred B, Makanga, Michael, Gbadoé, Adama Dodji, Premji, Zulfiqarali, Gaye, Oumar, Sagara, Issaka, Ubben, David, Cousin, Marc, Oladiran, Fiyinfolu, Sander, Oliver, Ogutu, Bernhards
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3161019/
https://www.ncbi.nlm.nih.gov/pubmed/21801345
http://dx.doi.org/10.1186/1475-2875-10-210
_version_ 1782210625704820736
author Kern, Steven E
Tiono, Alfred B
Makanga, Michael
Gbadoé, Adama Dodji
Premji, Zulfiqarali
Gaye, Oumar
Sagara, Issaka
Ubben, David
Cousin, Marc
Oladiran, Fiyinfolu
Sander, Oliver
Ogutu, Bernhards
author_facet Kern, Steven E
Tiono, Alfred B
Makanga, Michael
Gbadoé, Adama Dodji
Premji, Zulfiqarali
Gaye, Oumar
Sagara, Issaka
Ubben, David
Cousin, Marc
Oladiran, Fiyinfolu
Sander, Oliver
Ogutu, Bernhards
author_sort Kern, Steven E
collection PubMed
description BACKGROUND: Asymptomatic carriers of Plasmodium falciparum serve as a reservoir of parasites for malaria transmission. Identification and treatment of asymptomatic carriers within a region may reduce the parasite reservoir and influence malaria transmission in that area. METHODS: Using computer simulation, this analysis explored the impact of community screening campaigns (CSC) followed by systematic treatment of P. falciparum asymptomatic carriers (AC) with artemether-lumefantrine (AL) on disease transmission. The model created by Okell et al (originally designed to explore the impact of the introduction of treatment with artemisinin-based combination therapy on malaria endemicity) was modified to represent CSC and treatment of AC with AL, with the addition of malaria vector seasonality. The age grouping, relative distribution of age in a region, and degree of heterogeneity in disease transmission were maintained. The number and frequency of CSC and their relative timing were explored in terms of their effect on malaria incidence. A sensitivity analysis was conducted to determine the factors with the greatest impact on the model predictions. RESULTS: The simulation showed that the intervention that had the largest effect was performed in an area with high endemicity (entomological inoculation rate, EIR > 200); however, the rate of infection returned to its normal level in the subsequent year, unless the intervention was repeated. In areas with low disease burden (EIR < 10), the reduction was sustained for over three years after a single intervention. Three CSC scheduled in close succession (monthly intervals) at the start of the dry season had the greatest impact on the success of the intervention. CONCLUSIONS: Community screening and treatment of asymptomatic carriers with AL may reduce malaria transmission significantly. The initial level of disease intensity has the greatest impact on the potential magnitude and duration of malaria reduction. When combined with other interventions (e.g. long-lasting insecticide-treated nets, rapid diagnostic tests, prompt diagnosis and treatment, and, where appropriate, indoor residual spraying) the effect of this intervention can be sustained for many years, and it could become a tool to accelerate the reduction in transmission intensity to pre-elimination levels. Repeated interventions at least every other year may help to prolong the effect. The use of an effective diagnostic tool and a highly effective ACT, such as AL, is also vital. The modelling supports the evaluation of this approach in a prospective clinical trial to reduce the pool of infective vectors for malaria transmission in an area with marked seasonality.
format Online
Article
Text
id pubmed-3161019
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-31610192011-08-25 Community screening and treatment of asymptomatic carriers of Plasmodium falciparum with artemether-lumefantrine to reduce malaria disease burden: a modelling and simulation analysis Kern, Steven E Tiono, Alfred B Makanga, Michael Gbadoé, Adama Dodji Premji, Zulfiqarali Gaye, Oumar Sagara, Issaka Ubben, David Cousin, Marc Oladiran, Fiyinfolu Sander, Oliver Ogutu, Bernhards Malar J Research BACKGROUND: Asymptomatic carriers of Plasmodium falciparum serve as a reservoir of parasites for malaria transmission. Identification and treatment of asymptomatic carriers within a region may reduce the parasite reservoir and influence malaria transmission in that area. METHODS: Using computer simulation, this analysis explored the impact of community screening campaigns (CSC) followed by systematic treatment of P. falciparum asymptomatic carriers (AC) with artemether-lumefantrine (AL) on disease transmission. The model created by Okell et al (originally designed to explore the impact of the introduction of treatment with artemisinin-based combination therapy on malaria endemicity) was modified to represent CSC and treatment of AC with AL, with the addition of malaria vector seasonality. The age grouping, relative distribution of age in a region, and degree of heterogeneity in disease transmission were maintained. The number and frequency of CSC and their relative timing were explored in terms of their effect on malaria incidence. A sensitivity analysis was conducted to determine the factors with the greatest impact on the model predictions. RESULTS: The simulation showed that the intervention that had the largest effect was performed in an area with high endemicity (entomological inoculation rate, EIR > 200); however, the rate of infection returned to its normal level in the subsequent year, unless the intervention was repeated. In areas with low disease burden (EIR < 10), the reduction was sustained for over three years after a single intervention. Three CSC scheduled in close succession (monthly intervals) at the start of the dry season had the greatest impact on the success of the intervention. CONCLUSIONS: Community screening and treatment of asymptomatic carriers with AL may reduce malaria transmission significantly. The initial level of disease intensity has the greatest impact on the potential magnitude and duration of malaria reduction. When combined with other interventions (e.g. long-lasting insecticide-treated nets, rapid diagnostic tests, prompt diagnosis and treatment, and, where appropriate, indoor residual spraying) the effect of this intervention can be sustained for many years, and it could become a tool to accelerate the reduction in transmission intensity to pre-elimination levels. Repeated interventions at least every other year may help to prolong the effect. The use of an effective diagnostic tool and a highly effective ACT, such as AL, is also vital. The modelling supports the evaluation of this approach in a prospective clinical trial to reduce the pool of infective vectors for malaria transmission in an area with marked seasonality. BioMed Central 2011-07-29 /pmc/articles/PMC3161019/ /pubmed/21801345 http://dx.doi.org/10.1186/1475-2875-10-210 Text en Copyright ©2011 Kern et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Kern, Steven E
Tiono, Alfred B
Makanga, Michael
Gbadoé, Adama Dodji
Premji, Zulfiqarali
Gaye, Oumar
Sagara, Issaka
Ubben, David
Cousin, Marc
Oladiran, Fiyinfolu
Sander, Oliver
Ogutu, Bernhards
Community screening and treatment of asymptomatic carriers of Plasmodium falciparum with artemether-lumefantrine to reduce malaria disease burden: a modelling and simulation analysis
title Community screening and treatment of asymptomatic carriers of Plasmodium falciparum with artemether-lumefantrine to reduce malaria disease burden: a modelling and simulation analysis
title_full Community screening and treatment of asymptomatic carriers of Plasmodium falciparum with artemether-lumefantrine to reduce malaria disease burden: a modelling and simulation analysis
title_fullStr Community screening and treatment of asymptomatic carriers of Plasmodium falciparum with artemether-lumefantrine to reduce malaria disease burden: a modelling and simulation analysis
title_full_unstemmed Community screening and treatment of asymptomatic carriers of Plasmodium falciparum with artemether-lumefantrine to reduce malaria disease burden: a modelling and simulation analysis
title_short Community screening and treatment of asymptomatic carriers of Plasmodium falciparum with artemether-lumefantrine to reduce malaria disease burden: a modelling and simulation analysis
title_sort community screening and treatment of asymptomatic carriers of plasmodium falciparum with artemether-lumefantrine to reduce malaria disease burden: a modelling and simulation analysis
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3161019/
https://www.ncbi.nlm.nih.gov/pubmed/21801345
http://dx.doi.org/10.1186/1475-2875-10-210
work_keys_str_mv AT kernstevene communityscreeningandtreatmentofasymptomaticcarriersofplasmodiumfalciparumwithartemetherlumefantrinetoreducemalariadiseaseburdenamodellingandsimulationanalysis
AT tionoalfredb communityscreeningandtreatmentofasymptomaticcarriersofplasmodiumfalciparumwithartemetherlumefantrinetoreducemalariadiseaseburdenamodellingandsimulationanalysis
AT makangamichael communityscreeningandtreatmentofasymptomaticcarriersofplasmodiumfalciparumwithartemetherlumefantrinetoreducemalariadiseaseburdenamodellingandsimulationanalysis
AT gbadoeadamadodji communityscreeningandtreatmentofasymptomaticcarriersofplasmodiumfalciparumwithartemetherlumefantrinetoreducemalariadiseaseburdenamodellingandsimulationanalysis
AT premjizulfiqarali communityscreeningandtreatmentofasymptomaticcarriersofplasmodiumfalciparumwithartemetherlumefantrinetoreducemalariadiseaseburdenamodellingandsimulationanalysis
AT gayeoumar communityscreeningandtreatmentofasymptomaticcarriersofplasmodiumfalciparumwithartemetherlumefantrinetoreducemalariadiseaseburdenamodellingandsimulationanalysis
AT sagaraissaka communityscreeningandtreatmentofasymptomaticcarriersofplasmodiumfalciparumwithartemetherlumefantrinetoreducemalariadiseaseburdenamodellingandsimulationanalysis
AT ubbendavid communityscreeningandtreatmentofasymptomaticcarriersofplasmodiumfalciparumwithartemetherlumefantrinetoreducemalariadiseaseburdenamodellingandsimulationanalysis
AT cousinmarc communityscreeningandtreatmentofasymptomaticcarriersofplasmodiumfalciparumwithartemetherlumefantrinetoreducemalariadiseaseburdenamodellingandsimulationanalysis
AT oladiranfiyinfolu communityscreeningandtreatmentofasymptomaticcarriersofplasmodiumfalciparumwithartemetherlumefantrinetoreducemalariadiseaseburdenamodellingandsimulationanalysis
AT sanderoliver communityscreeningandtreatmentofasymptomaticcarriersofplasmodiumfalciparumwithartemetherlumefantrinetoreducemalariadiseaseburdenamodellingandsimulationanalysis
AT ogutubernhards communityscreeningandtreatmentofasymptomaticcarriersofplasmodiumfalciparumwithartemetherlumefantrinetoreducemalariadiseaseburdenamodellingandsimulationanalysis